Add BrightSurf on Google Email

Massachusetts General Hospital


Mass. General team creates functional, stem-cell-derived small bowel segments

A team of researchers at Massachusetts General Hospital has successfully created functional small intestine segments using human induced pluripotent stem cells. The segments were able to absorb nutrients and transfer glucose and fatty acids into the bloodstream when transplanted into rats. This breakthrough could potentially provide a ...

SourceMassachusetts General Hospital·JournalNature Communications·DateOct 10, 2017

Achieving National HIV/AIDS Strategy targets would save lives, be cost effective

A Massachusetts General Hospital analysis shows that achieving the treatment targets of the National HIV/AIDS Strategy by 2020 would prevent hundreds of thousands of new infections and deaths. Meeting NHAS goals would also demonstrate excellent value, with a cost-effectiveness ratio of $68,900 per quality-adjusted life year (QALY).

SourceMassachusetts General Hospital·JournalThe Journal of Infectious Diseases·DateSep 28, 2017

Cutbacks in foreign aid for HIV treatment would produce great harm, generate few savings

A 33% cutback in U.S. foreign aid for HIV treatment and prevention programs in South Africa and Côte d'Ivoire would result in devastating health and economic consequences, including over 500,000 additional cases of HIV and 1.6 million more deaths in the next decade. The study suggests that such cuts would produce proportionally greater...

SourceMassachusetts General Hospital·JournalAnnals of Internal Medicine·DateAug 28, 2017

Study estimates number of births, population prevalence of Down syndrome in nine states

A new study estimates the numbers of children born annually with Down syndrome and the prevalence of the condition in each of the nine US states. The study found that live birth prevalence ranged from 1 in 729 to 1 in 1,256 across the states, while elective termination reduced the number of births by an average of 39%.

SourceMassachusetts General Hospital·JournalAmerican Journal of Medical Genetics·DateAug 28, 2017

Mass. General team reports first response of central nervous system tumor to CAR T-cells

Researchers report a remarkable treatment response in a patient with recurrent diffuse large-B-cell lymphoma (DLBCL), where CAR T-cell therapy induced complete remission of a brain metastasis. The treatment also showed spontaneous re-expansion of CAR T-cells after a subcutaneous tumor recurrence, leading to further research into the me...

SourceMassachusetts General Hospital·JournalNew England Journal of Medicine·DateAug 28, 2017

Massachusetts General researchers explore why those with autism avoid eye contact

A team of investigators at Massachusetts General Hospital discovered that individuals with autism spectrum disorder experience overactivation in subcortical brain structures when viewing eye contact, leading to an aversion to direct gaze. This finding supports the hypothesis of an imbalance between excitatory and inhibitory signaling n...

SourceMassachusetts General Hospital·JournalScientific Reports·DateJun 15, 2017

Mass. General report outlines strategies to address racial, ethnic health care disparities

The report identifies five essential domains for successfully addressing disparities: knowing who to involve, shaping organizational culture, creating urgency and a vision, engaging the organization and audience, and harnessing the power of a collaborative network. These strategies were developed by participants in the Massachusetts Ge...

SourceMassachusetts General Hospital·JournalHealth Affairs·DateJun 12, 2017

Brain microenvironment makes HER2-positive breast cancer metastases resistant to treatment

A recent study led by Massachusetts General Hospital researchers has identified a novel mechanism behind the resistance of HER2-positive breast cancer metastases to treatment. The study found that overexpression of the HER3 gene contributes to this resistance, and combining anti-HER2 and anti-HER3 therapies can slow tumor growth.

SourceMassachusetts General Hospital·JournalScience Translational Medicine·DateMay 24, 2017